A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)

Clinical trial NCT03645330 · COMPLETED

Trial details

NCT number: NCT03645330
Sponsor: Chugai Pharmaceutical
Status: COMPLETED
Study type: OBSERVATIONAL

Non-small-Cell Lung Cancer

Start date: 2018-08-15
Primary completion: 2021-07-08
Enrollment: 1026

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.